Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Act Genomics (Ip) Limited currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners, which means that each of the company's active matters is being reviewed by a different individual. However, the 2 matters are housed within 1 distinct art unit, suggesting a high degree of technological consistency in the applications currently under review.
The data identifies YU, TIAN NMN as the busiest examiner for the portfolio, with 1 busiest examiner pending action. Because of the total workload, YU, TIAN NMN is responsible for 1 of the active prosecution matters. The remaining action is assigned to the other examiner, resulting in a split across the available pool.
For a patent practitioner, the concentration of all active matters in the 1 distinct art unit is a significant factor. While the examiners may have different personal styles, they are likely governed by the same supervisory policies and art unit-specific trends. Managing the portfolio in the Biotechnology & Pharmaceuticals sector under these conditions allows for a unified approach to the art unit's specific standards, even while addressing the individual concerns of YU, TIAN NMN and the other examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, TIAN NMN | 1 | 55.1% | +20.4% |
| HILL, GRACELYN MARKHAM | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18002054 | MICROSATELLITE INSTABILITY DETERMINING METHOD AND SYSTEM THEREOF | HILL, GRACELYN MARKHAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546431 | DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF | YU, TIAN NMN | 20d |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546431 | DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF | YU, TIAN NMN | 1681 | §103 | Final Rejection | 20d | Pending | Aug 15, 2023 |
| 18002054 | MICROSATELLITE INSTABILITY DETERMINING METHOD AND SYSTEM THEREOF | HILL, GRACELYN MARKHAM | — | §101§102§103§112 | Non-Final OA | — | Pending | Dec 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial